Kathryn A Wyman-Chick1, B J Scott1. 1. Pacific University School of Professional Psychology 190 SE 8 Ave Hillsboro OR 97123.
Abstract
BACKGROUND: The purpose of this study was to explore validity of the Clinical Dementia Rating Scale in measuring cognitive impairment among individuals with Parkinson's disease. The scale was created for use in patients with Alzheimer's disease and, to date, there have been no published studies examining if this tool is appropriate for patients with Parkinson's disease. METHODS: The data were obtained from the National Alzheimer's Coordinating Center database and included 490 subjects diagnosed with Parkinson's disease, further categorized as having Parkinson's disease dementia (n= 151), mild cognitive impairment (n= 186), or normal cognition (n = 153) by a treating physician. Sensitivity, specificity, positive predictive value and negative predictive values were calculated for the Clinical Dementia Rating Scale Global Score as well as the Sum of Boxes Score using existing cutoff scores. Finally, new cutoff scores were calculated using sensitivity and specificity values derived using Receiver Operating Characteristic curves. RESULTS: Sensitivity and specificity of the published Global Score cutoff scores for patients with dementia were .34 and .10, respectively. The newly calculated cutoff scores for patients with dementia yielded a sensitivity of .79 and a specificity of .96. The area under the curve was 0.92 (95% CI = 0.90-0.95). CONCLUSION: The CDR is a useful tool in identifying dementia in patients with Parkinson's disease when the cutoff scores are adjusted.
BACKGROUND: The purpose of this study was to explore validity of the Clinical Dementia Rating Scale in measuring cognitive impairment among individuals with Parkinson's disease. The scale was created for use in patients with Alzheimer's disease and, to date, there have been no published studies examining if this tool is appropriate for patients with Parkinson's disease. METHODS: The data were obtained from the National Alzheimer's Coordinating Center database and included 490 subjects diagnosed with Parkinson's disease, further categorized as having Parkinson's disease dementia (n= 151), mild cognitive impairment (n= 186), or normal cognition (n = 153) by a treating physician. Sensitivity, specificity, positive predictive value and negative predictive values were calculated for the Clinical Dementia Rating Scale Global Score as well as the Sum of Boxes Score using existing cutoff scores. Finally, new cutoff scores were calculated using sensitivity and specificity values derived using Receiver Operating Characteristic curves. RESULTS: Sensitivity and specificity of the published Global Score cutoff scores for patients with dementia were .34 and .10, respectively. The newly calculated cutoff scores for patients with dementia yielded a sensitivity of .79 and a specificity of .96. The area under the curve was 0.92 (95% CI = 0.90-0.95). CONCLUSION: The CDR is a useful tool in identifying dementia in patients with Parkinson's disease when the cutoff scores are adjusted.
Authors: S L Glatt; J P Hubble; K Lyons; A Paolo; A I Tröster; R E Hassanein; W C Koller Journal: Neuroepidemiology Date: 1996 Jan-Feb Impact factor: 3.282
Authors: Enikö Kövari; Gabriel Gold; François R Herrmann; Alessandra Canuto; Patrick R Hof; Constantin Bouras; Panteleimon Giannakopoulos Journal: Acta Neuropathol Date: 2003-04-10 Impact factor: 17.088
Authors: Sid E O'Bryant; Laura H Lacritz; James Hall; Stephen C Waring; Wenyaw Chan; Zeina G Khodr; Paul J Massman; Valerie Hobson; C Munro Cullum Journal: Arch Neurol Date: 2010-06
Authors: Philip D Harvey; Steven H Ferris; Jeffrey L Cummings; Keith A Wesnes; Chuanchieh Hsu; Roger M Lane; Sibel Tekin Journal: Am J Alzheimers Dis Other Demen Date: 2009-04-09 Impact factor: 2.035
Authors: Bruno Dubois; David Burn; Christopher Goetz; Dag Aarsland; Richard G Brown; Gerald A Broe; Dennis Dickson; Charles Duyckaerts; Jefferey Cummings; Serge Gauthier; Amos Korczyn; Andrew Lees; Richard Levy; Irene Litvan; Yoshikuni Mizuno; Ian G McKeith; C Warren Olanow; Werner Poewe; Cristina Sampaio; Eduardo Tolosa; Murat Emre Journal: Mov Disord Date: 2007-12 Impact factor: 10.338
Authors: Sandra Weintraub; David Salmon; Nathaniel Mercaldo; Steven Ferris; Neill R Graff-Radford; Helena Chui; Jeffrey Cummings; Charles DeCarli; Norman L Foster; Douglas Galasko; Elaine Peskind; Woodrow Dietrich; Duane L Beekly; Walter A Kukull; John C Morris Journal: Alzheimer Dis Assoc Disord Date: 2009 Apr-Jun Impact factor: 2.703
Authors: Asabe E Garba; George T Grossberg; Kimberly R Enard; Fabian J Jano; Emma N Roberts; Charlotte A Marx; Paula M Buchanan Journal: J Alzheimers Dis Rep Date: 2020-12-14
Authors: Dafne Piersma; Anselm B M Fuermaier; Dick De Waard; Ragnhild J Davidse; Jolieke De Groot; Michelle J A Doumen; Rudolf W H M Ponds; Peter P De Deyn; Wiebo H Brouwer; Oliver Tucha Journal: BMC Geriatr Date: 2018-09-17 Impact factor: 3.921
Authors: Julia Gallagher; Jacqueline Rick; Sharon X Xie; Pablo Martinez-Martin; Eugenia Mamikonyan; Alice Chen-Plotkin; Nabila Dahodwala; James Morley; John E Duda; John Q Trojanowski; Andrew Siderowf; Daniel Weintraub Journal: J Parkinsons Dis Date: 2021 Impact factor: 5.568